251 related articles for article (PubMed ID: 32023875)
1. Quercetin and Coumarin Inhibit Dipeptidyl Peptidase-IV and Exhibits Antioxidant Properties: In Silico, In Vitro, Ex Vivo.
Singh AK; Patel PK; Choudhary K; Joshi J; Yadav D; Jin JO
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32023875
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses.
Mohanty IR; Borde M; Kumar C S; Maheshwari U
Phytomedicine; 2019 Apr; 57():158-165. PubMed ID: 30668318
[TBL] [Abstract][Full Text] [Related]
3. α-Amylase and dipeptidyl peptidase-4 (DPP-4) inhibitory effects of
Quek A; Kassim NK; Lim PC; Tan DC; Mohammad Latif MA; Ismail A; Shaari K; Awang K
Pharm Biol; 2021 Dec; 59(1):964-973. PubMed ID: 34347568
[TBL] [Abstract][Full Text] [Related]
4. Soybean- and Lupin-Derived Peptides Inhibit DPP-IV Activity on In Situ Human Intestinal Caco-2 Cells and Ex Vivo Human Serum.
Lammi C; Bollati C; Ferruzza S; Ranaldi G; Sambuy Y; Arnoldi A
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30104520
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4.
Mishra A; Cross M; Hofmann A; Coster MJ; Karim A; Sattar A
J Comput Biol; 2019 Dec; 26(12):1470-1486. PubMed ID: 31390221
[TBL] [Abstract][Full Text] [Related]
6. Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats.
Eitah HE; Maklad YA; Abdelkader NF; Gamal El Din AA; Badawi MA; Kenawy SA
Toxicol Appl Pharmacol; 2019 Feb; 365():30-40. PubMed ID: 30576699
[TBL] [Abstract][Full Text] [Related]
7. Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV.
Pascual Alonso I; Valiente PA; Valdés-Tresanco ME; Arrebola Y; Almeida García F; Díaz L; García G; Guirola O; Pastor D; Bergado G; Sánchez B; Charli JL
Int J Biol Macromol; 2022 Jan; 196():120-130. PubMed ID: 34920066
[TBL] [Abstract][Full Text] [Related]
8. Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus.
Kalhotra P; Chittepu VCSR; Osorio-Revilla G; Gallardo-Velazquez T
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32075130
[TBL] [Abstract][Full Text] [Related]
9. Phytosterol supplements do not inhibit dipeptidyl peptidase-4.
Gupta A; Narkowicz CK; Al-Aubaidy HA; Jelinek HF; Nichols DS; Burgess JR; Jacobson GA
Diabetes Metab Syndr; 2020; 14(5):1475-1478. PubMed ID: 32771921
[TBL] [Abstract][Full Text] [Related]
10. Study on gluco-regulatory potential of glimepiride sulfonamide using in silico, in vitro and in vivo approaches.
Parmar HS; Bhinchar MK; Bhatia M; Chordia N; Raval I; Chauhan DS; Manivannan E; Jatwa R; Kumar A
Curr Pharm Des; 2014; 20(32):5212-7. PubMed ID: 24641189
[TBL] [Abstract][Full Text] [Related]
11. Features of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from dietary proteins.
Nongonierma AB; FitzGerald RJ
J Food Biochem; 2019 Jan; 43(1):e12451. PubMed ID: 31353485
[TBL] [Abstract][Full Text] [Related]
12. DPP-IV inhibitory potential of naringin: an in silico, in vitro and in vivo study.
Parmar HS; Jain P; Chauhan DS; Bhinchar MK; Munjal V; Yusuf M; Choube K; Tawani A; Tiwari V; Manivannan E; Kumar A
Diabetes Res Clin Pract; 2012 Jul; 97(1):105-11. PubMed ID: 22410395
[TBL] [Abstract][Full Text] [Related]
13. Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among
Yang Y; Shi CY; Xie J; Dai JH; He SL; Tian Y
Molecules; 2020 Jan; 25(1):. PubMed ID: 31906524
[No Abstract] [Full Text] [Related]
14. DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of
Kim BR; Kim HY; Choi I; Kim JB; Jin CH; Han AR
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103438
[TBL] [Abstract][Full Text] [Related]
15. Coumarin-Based Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Pre-ADME Analysis, Toxicity Profile, Computational Analysis, and In Vitro Enzyme Assay.
Vawhal PK; Jadhav SB; Kaushik S; Panigrahi KC; Nayak C; Urmee H; Khan SL; Siddiqui FA; Islam F; Eftekhari A; Alzahrani AR; Azlina MFN; Sarker MMR; Ibrahim IAA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770672
[TBL] [Abstract][Full Text] [Related]
16. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ
Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774
[TBL] [Abstract][Full Text] [Related]
17. The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo.
Uchii M; Sakai M; Hotta Y; Saeki S; Kimoto N; Hamaguchi A; Kitayama T; Kunori S
J Pharmacol Sci; 2017 Nov; 135(3):126-130. PubMed ID: 29113790
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
19. Rapid Identification of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides from Ruditapes philippinarum Hydrolysate.
Liu R; Zhou L; Zhang Y; Sheng NJ; Wang ZK; Wu TZ; Wang XZ; Wu H
Molecules; 2017 Oct; 22(10):. PubMed ID: 29027968
[TBL] [Abstract][Full Text] [Related]
20. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
Meduru H; Wang YT; Tsai JJ; Chen YC
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
